These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 37471330

  • 1. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E, Szubert A, Otike C, Namyalo I, Nambi E, Bamford A, Doerholt K, Gibb DM, Musiime V, Musoke P.
    PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
    [Abstract] [Full Text] [Related]

  • 2. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
    Rukuni R, Rehman AM, Mukwasi-Kahari C, Madanhire T, Kowo-Nyakoko F, McHugh G, Filteau S, Chipanga J, Simms V, Mujuru H, Ward KA, Ferrand RA, Gregson CL.
    Lancet Child Adolesc Health; 2021 Aug; 5(8):569-581. PubMed ID: 34139202
    [Abstract] [Full Text] [Related]

  • 3. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
    Gregson CL, Hartley A, Majonga E, McHugh G, Crabtree N, Rukuni R, Bandason T, Mukwasi-Kahari C, Ward KA, Mujuru H, Ferrand RA.
    Bone; 2019 Aug; 125():96-102. PubMed ID: 31082498
    [Abstract] [Full Text] [Related]

  • 4. Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe.
    Rukuni R, Simms V, Rehman AM, Mukwasi-Kahari C, Mujuru H, Ferrand RA, Gregson CL.
    AIDS; 2023 Apr 01; 37(5):759-767. PubMed ID: 36728418
    [Abstract] [Full Text] [Related]

  • 5. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group.
    HIV Med; 2017 Apr 01; 18(4):235-244. PubMed ID: 27477214
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 7. Identifying sex-specific risk factors for low bone mineral density in adolescent runners.
    Tenforde AS, Fredericson M, Sayres LC, Cutti P, Sainani KL.
    Am J Sports Med; 2015 Jun 01; 43(6):1494-504. PubMed ID: 25748470
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y, Sun J, Kong K, Zhang R, Zhang R, Liu L, Wang J, Shen Y, Wu L, Zheng Z, Sun M, Qi T, Wang Z, Tang Y, Sun J, Song W, Yang J, Xu S, Zhao B, Shan F, Qin A, Lu H, Chen J.
    Arch Osteoporos; 2024 Jul 02; 19(1):56. PubMed ID: 38954143
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J, Viget N, Drumez E, Cortet B, Robineau O.
    Med Mal Infect; 2018 Oct 02; 48(7):442-448. PubMed ID: 29699830
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density in children and adolescents with perinatal HIV infection.
    DiMeglio LA, Wang J, Siberry GK, Miller TL, Geffner ME, Hazra R, Borkowsky W, Chen JS, Dooley L, Patel K, van Dyke RB, Fielding RA, Gurmu Y, Jacobson DL, Pediatric HIVAIDS Cohort Study (PHACS).
    AIDS; 2013 Jan 14; 27(2):211-20. PubMed ID: 23032412
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.
    HIV Med; 2015 Apr 14; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [Abstract] [Full Text] [Related]

  • 12. Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
    Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team.
    Trials; 2024 Jul 22; 25(1):499. PubMed ID: 39039558
    [Abstract] [Full Text] [Related]

  • 13. Individualized evaluation of lumbar bone mineral density and bone mineral apparent density in children and adolescents.
    Duran I, Martakis K, Rehberg M, Semler O, Schoenau E.
    Arch Osteoporos; 2018 Oct 29; 13(1):117. PubMed ID: 30374788
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density, nutrient intake, and physical activity among young women from Uganda.
    Heffron R, Muwonge TR, Boyer J, Matovu F, Zia Y, Bagaya M, Ssebuliba T, Morrison S, Bambia F, Nsubuga R, Badaru J, Stein G, Mugwanya KK, Wyatt C, Baeten JM, Yin MT, Mujugira A, Kampala Women’s Bone Study Team.
    Arch Osteoporos; 2022 Oct 11; 17(1):134. PubMed ID: 36216962
    [Abstract] [Full Text] [Related]

  • 15. Association Between Vitamin D Insufficiency and Impaired Bone Density Among Adolescents With Perinatally Acquired HIV Infection.
    Dzavakwa NV, Simms V, Gregson CL, Chisenga M, Filteau S, Kasonka L, Kranzer K, Banda-Mabuda H, Mujuru H, Redzo N, Mukwasi-Kahari C, Rowland-Jones SL, Schaible UE, Ferrand RA, VITALITY team .
    Open Forum Infect Dis; 2024 Sep 11; 11(9):ofae442. PubMed ID: 39301108
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 11; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 17. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
    Rukuni R, Gregson C, Kahari C, Kowo F, McHugh G, Munyati S, Mujuru H, Ward K, Filteau S, Rehman AM, Ferrand R.
    BMJ Open; 2020 Feb 09; 10(2):e031792. PubMed ID: 32041852
    [Abstract] [Full Text] [Related]

  • 18. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
    Chisati EM, Constantinou D, Lampiao F.
    PLoS One; 2020 Feb 09; 15(1):e0227893. PubMed ID: 31935270
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of anthropometry as an alternative to DXA as predictor of low bone mineral density in children and adolescents with cystic fibrosis.
    Silva Júnior CCD, Marques Queiroz DJ, de Paiva MP, Lopes MT, da Cunha Costa M, de Matos Bezerra PG, de Carvalho Costa MJ, Silva AS, Filho JM, Braga Cartaxo CG, da Conceição Rodrigues Gonçalves M.
    Clin Nutr ESPEN; 2021 Oct 09; 45():229-235. PubMed ID: 34620322
    [Abstract] [Full Text] [Related]

  • 20. The natural course of bone mineral density in transgender youth before medical treatment; a cross sectional study.
    van der Loos MATC, Boogers LS, Klink DT, den Heijer M, Wiepjes CM, Hannema SE.
    Eur J Endocrinol; 2024 Sep 30; 191(4):426-432. PubMed ID: 39353071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.